Clinical Trial Search - Pediatric Prurigo Nodularis - CPL (US)
$18.75 CPLactive✓ verified live 7h ago
MaxBounty · Health & Wellness / Clinical Trials & Research · US · live 54 days · compare this product across geos & networks →
Model this payoutPrefills the fixed conversion payout; your traffic assumptions stay in your browser.
Run this offer — join MaxBounty →
Should you run this?
- 💸 This product pays more elsewhere: $225.00 on MaxBounty (US) — 1100% more than this listing (different geo, same network). All 18 versions →
- ⚖️ Payout vs its vertical: beats 26% of the 3666 live Health & Fitness offers we track (vertical median $26.26).
- 🛡️ Stability: Payout unchanged since we started tracking it 54 days ago.
Payout history
🔒 1 older event is hidden — create a free account to see this offer's full payout history.
Description
This clinical study is researching the investigational injectable medication dupilumab for treating Prurigo Nodularis in children and adolescents. Enrolled participants receive the study medication via injection 6 to 12 times over approximately six months.
Converts on qualified parent/guardian lead submission
Targeting: Parents or guardians of children aged 0–17 with a diagnosis of Prurigo Nodularis. The child's itch must rate at least $7/10$, and they must have at least six affected bumps across two or more areas of the body.
Restrictions: Must not have ever used the self-injectable medication Dupixent (Dupilumab). The child cannot currently be taking Gabarone (Gabapentin), Lyrica (Pregabalin), or Thalomid (Thalidomide). No incentive traffic is permitted. Creative and copy must be approved by the advertiser before launch.
Live Geos.
Converts on qualified parent/guardian lead submission
Targeting: Parents or guardians of children aged 0–17 with a diagnosis of Prurigo Nodularis. The child's itch must rate at least $7/10$, and they must have at least six affected bumps across two or more areas of the body.
Restrictions: Must not have ever used the self-injectable medication Dupixent (Dupilumab). The child cannot currently be taking Gabarone (Gabapentin), Lyrica (Pregabalin), or Thalomid (Thalidomide). No incentive traffic is permitted. Creative and copy must be approved by the advertiser before launch.
Live Geos.
Change log (1 events)
🔒 1 older event is hidden — create a free account to see this offer's full payout history.
No change events recorded yet.
Reviews (0)
No reviews yet — be the first to share your experience.
Log in or create a free account to review this offer.
Payout looks wrong or a link is dead? Report a problem with this offer — we check it against the source.